Koichi Fukumoto

Koichi Fukumoto

Auto-generated profile, based on publicly available information

Koichi Fukumoto

Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Lung Cancer
Verified
Journal Article
Closed access
KFKoichi Fukumoto
Koichi Fukumoto
SMShoichi Mori
Shoichi Mori
YSYasushi Shintani
Yasushi Shintani
JOJiro Okami
Jiro Okami
HIHiroyuki Ito
Hiroyuki Ito
IYIchiro Yoshino
Ichiro Yoshino

1 January 2015 in Journal of Epidemiology
Verified
Journal Article
Open access
KFKoichi Fukumoto
Koichi Fukumoto
TTTetsuo Taniguchi
Tetsuo Taniguchi
NUNoriyasu Usami
Noriyasu Usami
KKKoji Kawaguchi
Koji Kawaguchi
TFTakayuki Fukui
Takayuki Fukui
KYKohei Yokoi
Kohei Yokoi
The ABO blood group is reported to be associated with the incidence and patient survival for several types of malignancies. We conducted a retrospective study to evaluate the prognostic significance of the ABO blood group in patients with resected non-small cell lung cancer (NSCLC). A total of 333 patients (218 men and 115 women) with resected NSCLC were included in this study. In addition to age, sex, smoking status, preoperative serum carcinoembryonic antigen (CEA) level, operative procedure, histology of tumors, pathological stage (p-stage), and adjuvant therapy, the association between the ABO blood group and survival was explored. The 5-year overall and disease-free survival rates were 83.0% and 71.6% for blood group O, 67.2% and 62.3% for blood group A, 68.8% and 68.8% for blood group B and 69.2% and 65.3% for blood group AB, respectively. A multivariate analysis for overall survival showed the ABO blood group (group A vs. group O: HR 2.47, group AB vs. group O: HR 3.62) to be an independent significant prognostic factor, in addition to age, sex, smoking status, p-stage, and serum CEA level. A multivariate analysis for disease-free survival also showed the ABO blood group to be an independent significant prognostic factor. The ABO blood group is an independent prognostic factor in patients with resected NSCLC. Studies of other larger cohorts are therefore needed to confirm the relationship between the ABO blood group and the prognosis among patients with resected NSCLC.

22 February 2016 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
TFTakayuki Fukui
Takayuki Fukui
TOToshiki Okasaka
Toshiki Okasaka
KKKoji Kawaguchi
Koji Kawaguchi
KFKoichi Fukumoto
Koichi Fukumoto
SNShota Nakamura
Shota Nakamura
KYKohei Yokoi
Kohei Yokoi

6 March 2017 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
KFKoichi Fukumoto
Koichi Fukumoto
TFTakayuki Fukui
Takayuki Fukui
TOToshiki Okasaka
Toshiki Okasaka
KKKoji Kawaguchi
Koji Kawaguchi
SNShota Nakamura
Shota Nakamura
KYKohei Yokoi
Kohei Yokoi

25 October 2023 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
MGMadoka Goto
Madoka Goto
KFKoichi Fukumoto
Koichi Fukumoto
YIYasuhisa Ichikawa
Yasuhisa Ichikawa
HTHideki Tsubouchi
Hideki Tsubouchi
MUMika Uchiyama
Mika Uchiyama
SMShoichi Mori
Shoichi Mori
Background: Spontaneous regression of malignant tumors is a rare phenomenon, especially in primary lung cancer. The underlying mechanisms remain unclear, but they may often involve immunological mechanisms. Case presentation: In January 2020, a 78-year-old female underwent examination during follow-up of interstitial pneumonia. Chest X-ray and computed tomography (CT) scan revealed a 1.2 × 1.2 cm nodule in the left lower lobe. Based on CT-guided percutaneous transthoracic needle biopsy (PTNB), it was diagnosed as small cell lung cancer (SCLC). Immunohistochemical staining showed that tumor cells were positive for CD56, synaptophysin, and chromogranin A. Twenty-three days after the CT-guided PTNB, repeat CT scan showed that the tumor size regressed to 0.6 × 0.6 cm. The tumor showed positive uptake in fluorodeoxyglucose (FDG) positron emission tomography (PET)–CT. The maximum standardized uptake value of the nodule was 2.24. PET–CT and enhanced magnetic resonance imaging of the brain showed no distant or lymph node metastasis. The patient’s preoperative disease was diagnosed as cT1aN0M0, stageIA1, SCLC. In March 2020, she underwent left lower lobectomy and mediastinal lymph node dissection. Pathological examination of the resected specimen showed that the small tumor cells were dense with a high nucleus to cytoplasm ratio, and the morphological diagnosis was small cell carcinoma. The resected tumor size regressed to 0.05 × 0.02 cm, and no lymph node metastasis was observed. Because it was extremely small, immunohistochemical staining could not be conducted. Active fibrosis and inflammation were present around the tumor. Finally, the patient was pathologically diagnosed as SCLC pT1miN0M0, stage IA1. The patient is alive without recurrence 23 months after surgery with no adjuvant therapy. Conclusions: We present a rare surgical case of pathologically confirmed spontaneous regression of SCLC after CT-guided PTNB. Although spontaneous regression is extremely rare, we should recognize this phenomenon.

7 December 2020 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
KFKoichi Fukumoto
Koichi Fukumoto
MGMadoka Goto
Madoka Goto
YIYasuhisa Ichikawa
Yasuhisa Ichikawa
YKYuta Kawasumi
Yuta Kawasumi
MUMika Uchiyama
Mika Uchiyama
SMShoichi Mori
Shoichi Mori
Background: There have been few reports on surgically treated primary lung cancer accompanied by contralateral partial anomalous pulmonary venous connection (PAPVC). In such cases, repair of the PAPVC might be necessary to avoid postoperative right-heart failure due to the increased flow of the left-to-right shunt. Case presentation: We herein report a case of lung adenocarcinoma treated by left-upper lobectomy with bronchoplasty and pulmonary arterial angioplasty after induction chemoradiation therapy followed by surgical correction of the PAPVC in the right-upper lobe. The patient is alive without recurrence of lung cancer or any symptoms of heart failure 17 months after pulmonary resection. Conclusion: When considering performing major pulmonary resection for lung tumor, thoracic surgeons should pay close attention to the presence of a PAPVC not only on the ipsilateral side of the lung tumor, but also the contralateral side, although it is a rare phenomenon.